The 36th Annual Healthcare Conference will be held in New York, December 3-5, 2024
I-Mab (NASDAQ: IMAB, the “Company”), a U.S.-based global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024.
https://mma.prnewswire.com/media/2377824/I_MAB_Logo.jpg
Piper Sandler 36th Annual Healthcare Conference Presentation Details
Presentation Time Wednesday, December 4 at4:30 p.m. ET
Presenters Sean Fu, PhD, MBA, Chief Executive Officer
Phillip Dennis, MD, PhD, Chief Medical Officer
Webcast link Here
Meetings One-on-one and small group meetings:December 3 - 4, 2024
Management Sean Fu, PhD, MBA, Chief Executive Officer
Participants Joseph Skelton, Chief Financial Officer
Phillip Dennis, MD, PhD, Chief Medical Officer
Tyler Ehler, Senior Director, Investor Relations
The webcast will also be available under “Event Calendar” onI-Mab’sIR websiteathttps://ir.i-mabbiopharma.com/
For more information, please contact your Piper Sandler representative.
About I-Mab
I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X.
For more information, please contact:
Tyler EhlerSenior Director, Investor RelationsIR@imabbio.com
https://c212.net/c/img/favicon.png?sn=CN62966&sd=2024-11-21
View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-to-participate-at-the-piper-sandler-healthcare-conference-302312202.html
SOURCE I-Mab Biopharma
https://rt.newswire.ca/rt.gif?NewsItemId=CN62966&Transmission_Id=202411210700PR_NEWS_USPR_____CN62966&DateId=20241121
COMTEX_460033441/1005/2024-11-21T07:00:34